TY - JOUR
T1 - Predicting Delirium Risk Using an Automated Mayo Delirium Prediction Tool
T2 - Development and Validation of a Risk-Stratification Model
AU - Pagali, Sandeep R.
AU - Miller, Donna
AU - Fischer, Karen
AU - Schroeder, Darrell
AU - Egger, Norman
AU - Manning, Dennis M.
AU - Lapid, Maria I.
AU - Pignolo, Robert J.
AU - Burton, M. Caroline
N1 - Funding Information:
Funding Sources: This work was supported by the small-grants program of the Mayo Clinic Center for Clinical and Translational Science (to S.R.P.), made possible by CTSA Grant Number UL1 TR000135 , from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), and by the Robert and Arlene Kogod Professorship in Geriatric Medicine (to R.J.P.). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official view of NIH.
Publisher Copyright:
© 2020 Mayo Foundation for Medical Education and Research
PY - 2021/5
Y1 - 2021/5
N2 - Objective: To develop a delirium risk-prediction tool that is applicable across different clinical patient populations and can predict the risk of delirium at admission to hospital. Methods: This retrospective study included 120,764 patients admitted to Mayo Clinic between January 1, 2012, and December 31, 2017, with age 50 and greater. The study group was randomized into a derivation cohort (n=80,000) and a validation cohort (n=40,764). Different risk factors were extracted and analyzed using least absolute shrinkage and selection operator (LASSO) penalized logistic regression. Results: The area under the receiver operating characteristic curve (AUROC) for Mayo Delirium Prediction (MDP) tool using derivation cohort was 0.85 (95% confidence interval [CI],. 846 to. 855). Using the regression coefficients obtained from the derivation cohort, predicted probability of delirium was calculated for each patient in the validation cohort. For the validation cohort, AUROC was 0.84 (95% CI,. 834 to. 847). Patients were classified into 1 of the 3 risk groups, based on their predicted probability of delirium: low (≤5%), moderate (6% to 29%), and high (≥30%). In the derivation cohort, observed incidence of delirium was 1.7%, 12.8%, and 44.8% (low, moderate, and high risk, respectively), which is similar to the incidence rates in the validation cohort of 1.9%, 12.7%, and 46.3%. Conclusion: The Mayo Delirium Prediction tool was developed from a large heterogeneous patient population with good validation results and appears to be a reliable automated tool for delirium risk prediction with hospitalization. Further prospective validation studies are required.
AB - Objective: To develop a delirium risk-prediction tool that is applicable across different clinical patient populations and can predict the risk of delirium at admission to hospital. Methods: This retrospective study included 120,764 patients admitted to Mayo Clinic between January 1, 2012, and December 31, 2017, with age 50 and greater. The study group was randomized into a derivation cohort (n=80,000) and a validation cohort (n=40,764). Different risk factors were extracted and analyzed using least absolute shrinkage and selection operator (LASSO) penalized logistic regression. Results: The area under the receiver operating characteristic curve (AUROC) for Mayo Delirium Prediction (MDP) tool using derivation cohort was 0.85 (95% confidence interval [CI],. 846 to. 855). Using the regression coefficients obtained from the derivation cohort, predicted probability of delirium was calculated for each patient in the validation cohort. For the validation cohort, AUROC was 0.84 (95% CI,. 834 to. 847). Patients were classified into 1 of the 3 risk groups, based on their predicted probability of delirium: low (≤5%), moderate (6% to 29%), and high (≥30%). In the derivation cohort, observed incidence of delirium was 1.7%, 12.8%, and 44.8% (low, moderate, and high risk, respectively), which is similar to the incidence rates in the validation cohort of 1.9%, 12.7%, and 46.3%. Conclusion: The Mayo Delirium Prediction tool was developed from a large heterogeneous patient population with good validation results and appears to be a reliable automated tool for delirium risk prediction with hospitalization. Further prospective validation studies are required.
UR - http://www.scopus.com/inward/record.url?scp=85100749693&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85100749693&partnerID=8YFLogxK
U2 - 10.1016/j.mayocp.2020.08.049
DO - 10.1016/j.mayocp.2020.08.049
M3 - Article
C2 - 33581839
AN - SCOPUS:85100749693
SN - 0025-6196
VL - 96
SP - 1229
EP - 1235
JO - Mayo Clinic proceedings
JF - Mayo Clinic proceedings
IS - 5
ER -